Breast cancer recurrence diagnosis suspected on tumor marker rising (original) (raw)
Influence of CA 15-3 blood level and doubling time on diagnostic performances of 18F-FDG PET in breast cancer patients with occult recurrence
Natacha Heutte
Nuclear Medicine Communications, 2007
View PDFchevron_right
Tumour markers and FDG PET/CT for prediction of disease relapse in patients with breast cancer
Zora Baretta, Giorgio Saladini
European Journal of Nuclear Medicine and Molecular Imaging, 2011
View PDFchevron_right
Comparative diagnostic accuracy of 18F-FDG PET/CT for breast cancer recurrence
Matteo Bauckneht
Breast Cancer: Targets and Therapy
View PDFchevron_right
Comparative diagnostic accuracy of 18F-FDG PET/CT for breast cancer recurrence.
Matteo Bauckneht
View PDFchevron_right
Effectiveness of 18F-FDG PET/CT in detection of loco-regional recurrence of breast cancer in comparison to CT alone
mai khalifa
Sohag Medical Journal, 2019
View PDFchevron_right
The Role of Whole-Body Fluorine-18-FDG Positron Emission Tomography in the Detection of Recurrence in Symptomatic Patients with Stages II and III Breast Cancer
Richard Turnage
World Journal of Surgery, 2006
View PDFchevron_right
Role of F-18 FDG PET/CT in Patients with Suspected Recurrent Breast Cancer: Additional Value over Conventional Imaging Modalities
Mehrdad Bakhshayesh-karam
Archives of Breast Cancer
View PDFchevron_right
The role of FDG-PET/CT in suspected recurrence of breast cancer
Luda Guralnik
Cancer, 2006
View PDFchevron_right
Comparison of diagnostic accuracy of 18F-fluoroestradiol and 18F-fluorodeoxyglucose positron emission tomography/computed tomography for breast cancer recurrence in patients with a history of estrogen receptor-positive primary breast cancer
Jungsu Oh
2020
View PDFchevron_right
The Place of Whole-Body PET FDG for the Diagnosis of Distant Recurrence of Breast Cancer
Stanislas Pauwels
Clinical Positron Imaging, 2000
View PDFchevron_right
The utility of 18 F-FDG PET/CT for suspected recurrent breast cancer: impact and prognostic stratification
Michael Macmanus
Cancer imaging : the official publication of the International Cancer Imaging Society, 2014
View PDFchevron_right
A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence
Theodoros Arvanitis
Health Technology Assessment, 2010
View PDFchevron_right
Role of 18F- FDG-PET/CT in Restaging of Breast Cancer Patients with High Tumour Markers and Equivocal Radiological Imaging
Khalid Taalab
The Egyptian Journal Nuclear Medicine
View PDFchevron_right
Tumour Markers and Molecular Imaging with FDG PET/CT in Breast Cancer: Their Combination for Improving the Prediction of Disease Relapse
Pier Muzzio, Zora Baretta
Positron Emission Tomography - Current Clinical and Research Aspects, 2012
View PDFchevron_right
Could the serial determination of Ca15.3 serum improve the diagnostic accuracy of PET/CT? Results from small population with previous breast cancer
Zora Baretta, C. Ghiotto, Giorgio Saladini, Anna Cervino, Fernando Bozza
Annals of Nuclear Medicine, 2011
View PDFchevron_right
Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma
Jamshid Maddahi
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998
View PDFchevron_right
Examining the evolving utility of 18FDG-PET/CT in breast cancer recurrence
Juhi Motiani
Translational Cancer Research, 2020
View PDFchevron_right
Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer
Joon Jeong
PloS one, 2017
View PDFchevron_right
Correlation between Cancer Antigen 15.3 Value and Qualitative and Semiquantitative Parameters of Positron Emission Tomography/Computed Tomography in Breast Cancer Patients
Giorgio Saladini, Anna Cervino, Fernando Bozza
Current Radiopharmaceuticals, 2014
View PDFchevron_right
Correlation between PET/CT results and histological and immunohistochemical findings in breast carcinomas
Juliana Souza
Radiologia Brasileira, 2014
View PDFchevron_right
CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients
Ciro Maiello, Mariarosaria Incoronato
BMC Cancer, 2014
View PDFchevron_right
Standardized uptake value of 18F-fluorodeoxyglucose positron emission tomography for prediction of tumor recurrence in breast cancer beyond tumor burden
Joon Jeong
Breast cancer research : BCR, 2014
View PDFchevron_right
Is 18F-FDG PET/CT useful for imaging and management of patients with suspected occult recurrence of cancer?
Luda Guralnik
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004
View PDFchevron_right
The clinical utility of FDG-PET/CT in follow up and restaging of breast cancer patients
Marc Harth
The Egyptian Journal of Radiology and Nuclear Medicine, 2013
View PDFchevron_right
Special Relevance of FDG-PET as an Upfront Diagnostic Modality at Initial Diagnosis and in Suspected Recurrence in Patients of Breast Carcinoma Hailing From Lower Socioeconomic Status Owing to Relative Late Presentation: A Pilot Study in a Medical College Hospital Setting in India
Spoorthy Shetty
Indian Journal of Surgical Oncology, 2014
View PDFchevron_right
Role of [F-18] 2-Deoxy-2-Fluoro-d-Glucose PET and PET/CT in Staging and Follow-Up of Breast Cancer
Abass Alavi, Ayşe Mavi
2009
View PDFchevron_right
The impact of FDG-PET/CT on the management of breast cancer patients with elevated tumor markers and negative or equivocal conventional imaging modalities
Julia Malamitsi
Nuclear Medicine Communications, 2011
View PDFchevron_right
Tumor Marker–Guided PET in Breast Cancer Patients—A Recipe for a Perfect Wedding
Anna Cervino, Pier Muzzio
Clinical Nuclear Medicine, 2012
View PDFchevron_right
Early detection of cancer recurrence: 18F-FDG PET/CT can make a difference in diagnosis and patient care
Abraham Kuten
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007
View PDFchevron_right
Pitfalls and artifacts of FDG PET/CT in recurrent breast cancer patients
Marta Burei
Clinical and Translational Imaging, 2017
View PDFchevron_right
The Relationship between 18-FDG-PET/CT and Clinicopathologic Features, Pathologic Response in Patients with Locally Advanced Breast Cancer
Melih Simsek
The Eurasian Journal of Medicine
View PDFchevron_right
The predictive of tumour markers CA 15-3, TPS and CEA in breast cancer recurrence
M. Given
The Breast, 2000
View PDFchevron_right
The Role of FDG-PET/CT in Ovarian Cancer Patients with High Tumor Markers or Suspicious Lesion on Contrast-Enhanced CT in Evaluation of Recurrence and/or in Determination of Intraabdominal Metastases
Pelin Kara
Revista Espanola De Medicina Nuclear
View PDFchevron_right